Comparison of Targeted and Untargeted Approaches in Breath Analysis for the Discrimination of Lung Cancer from Benign Pulmonary Diseases and Healthy Persons.


Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
29 Apr 2021
Historique:
received: 28 03 2021
revised: 23 04 2021
accepted: 27 04 2021
entrez: 5 5 2021
pubmed: 6 5 2021
medline: 25 5 2021
Statut: epublish

Résumé

The aim of the present study was to compare the efficiency of targeted and untargeted breath analysis in the discrimination of lung cancer (Ca+) patients from healthy people (HC) and patients with benign pulmonary diseases (Ca-). Exhaled breath samples from 49 Ca+ patients, 36 Ca- patients and 52 healthy controls (HC) were analyzed by an SPME-GC-MS method. Untargeted treatment of the acquired data was performed with the use of the web-based platform XCMS Online combined with manual reprocessing of raw chromatographic data. Machine learning methods were applied to estimate the efficiency of breath analysis in the classification of the participants. Results: Untargeted analysis revealed 29 informative VOCs, from which 17 were identified by mass spectra and retention time/retention index evaluation. The untargeted analysis yielded slightly better results in discriminating Ca+ patients from HC (accuracy: 91.0%, AUC: 0.96 and accuracy 89.1%, AUC: 0.97 for untargeted and targeted analysis, respectively) but significantly improved the efficiency of discrimination between Ca+ and Ca- patients, increasing the accuracy of the classification from 52.9 to 75.3% and the AUC from 0.55 to 0.82. Conclusions: The untargeted breath analysis through the inclusion and utilization of newly identified compounds that were not considered in targeted analysis allowed the discrimination of the Ca+ from Ca- patients, which was not achieved by the targeted approach.

Identifiants

pubmed: 33946997
pii: molecules26092609
doi: 10.3390/molecules26092609
pmc: PMC8125376
pii:
doi:

Substances chimiques

Biomarkers 0
Volatile Organic Compounds 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Stavros Niarchos Foundation(SNF)
ID : Project No.: 5394.02.07

Références

J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Oct 15;877(28):3366-77
pubmed: 19505855
J Biotechnol. 2017 Nov 10;261:137-141
pubmed: 28554829
Curr Protoc Mol Biol. 2016 Apr 01;114:30.4.1-30.4.32
pubmed: 27038389
Sensors (Basel). 2016 Nov 10;16(11):
pubmed: 27834896
PLoS One. 2018 Nov 15;13(11):e0207082
pubmed: 30439966
Metabolomics. 2011 Sep;7(3):307-328
pubmed: 21949491
J Breath Res. 2008 Dec;2(4):046001
pubmed: 21386188
Nutr Cancer. 1997;29(2):152-6
pubmed: 9427979
Lung Cancer. 2010 Feb;67(2):227-31
pubmed: 19409642
Metabolites. 2020 Aug 03;10(8):
pubmed: 32756521
Sensors (Basel). 2017 Feb 04;17(2):
pubmed: 28165388
J Breath Res. 2011 Dec;5(4):046008
pubmed: 22071773
Eur Respir J. 2017 Apr 26;49(4):
pubmed: 28446552
Cancers (Basel). 2020 May 16;12(5):
pubmed: 32429446
Sci Rep. 2014 Dec 08;4:7312
pubmed: 25482491
Nat Protoc. 2018 Apr;13(4):633-651
pubmed: 29494574
J Clin Med. 2020 Dec 24;10(1):
pubmed: 33374433
J Chromatogr A. 2010 Dec 24;1217(52):8308-16
pubmed: 21081237
J Cell Biochem Suppl. 1997;27:100-5
pubmed: 9591199
Anal Chem. 2001 Apr 1;73(7):1646-9
pubmed: 11321322
J Breath Res. 2014 Jun;8(2):027105
pubmed: 24713999
J Sep Sci. 2020 Jan;43(1):226-240
pubmed: 31826324
Biomed Chromatogr. 2015 Jun;29(6):961-5
pubmed: 25421853
Talanta. 2004 Oct 8;64(2):458-66
pubmed: 18969626
Anal Bioanal Chem. 2012 Jul;404(1):141-6
pubmed: 22660158
Clin Chim Acta. 2010 Nov 11;411(21-22):1637-44
pubmed: 20542019
Anal Chem. 2017 Sep 5;89(17):8689-8695
pubmed: 28752757
J Chromatogr B Analyt Technol Biomed Life Sci. 2019 May 1;1114-1115:146-153
pubmed: 30745111
Lung Cancer. 2019 Sep;135:123-129
pubmed: 31446984
J Breath Res. 2016 Oct 12;10(4):046007
pubmed: 27732569
PLoS One. 2011 Apr 08;6(4):e18471
pubmed: 21494609
Food Chem. 2008 Sep 1;110(1):233-8
pubmed: 26050188
Nat Rev Mol Cell Biol. 2012 Mar 22;13(4):263-9
pubmed: 22436749
Cancer Biomark. 2014;14(5):371-9
pubmed: 25171479
Metabolites. 2020 Aug 27;10(9):
pubmed: 32867165
Trends Mol Med. 2015 Oct;21(10):633-644
pubmed: 26432020
J Chromatogr B Analyt Technol Biomed Life Sci. 2019 Jan 15;1105:136-147
pubmed: 30584978
Anal Chem. 2016 Jan 5;88(1):524-45
pubmed: 26637011
Chem Soc Rev. 2014 Mar 7;43(5):1423-49
pubmed: 24305596
Sci Rep. 2020 Jul 2;10(1):10918
pubmed: 32616798
J Breath Res. 2019 May 17;13(3):032001
pubmed: 30965287
J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Nov 15;879(30):3360-6
pubmed: 21982505
J Chromatogr A. 2014 Sep 5;1358:155-64
pubmed: 25063004
J Breath Res. 2018 Sep 14;12(4):046013
pubmed: 30102249
Metabolomics. 2017;13(10):110
pubmed: 28867989
Environ Health Perspect. 1996 Dec;104 Suppl 6:1251-6
pubmed: 9118901
Biomed Chromatogr. 2009 May;23(5):551-6
pubmed: 19039804
Eur Respir Rev. 2019 Jun 26;28(152):
pubmed: 31243097

Auteurs

Michalis Koureas (M)

Department of Hygiene and Epidemiology, University Hospital of Larissa, Faculty of Medicine, University of Thessaly, 22 Papakyriazi Street, 41222 Larissa, Greece.

Dimitrios Kalompatsios (D)

Department of Hygiene and Epidemiology, University Hospital of Larissa, Faculty of Medicine, University of Thessaly, 22 Papakyriazi Street, 41222 Larissa, Greece.

Grigoris D Amoutzias (GD)

Bioinformatics Laboratory, Department of Biochemistry and Biotechnology, University of Thessaly, 41500 Larissa, Greece.

Christos Hadjichristodoulou (C)

Department of Hygiene and Epidemiology, University Hospital of Larissa, Faculty of Medicine, University of Thessaly, 22 Papakyriazi Street, 41222 Larissa, Greece.

Konstantinos Gourgoulianis (K)

Respiratory Medicine Department, University Hospital of Larissa, Faculty of Medicine, University of Thessaly, 41110 Larissa, Greece.

Andreas Tsakalof (A)

Department of Hygiene and Epidemiology, University Hospital of Larissa, Faculty of Medicine, University of Thessaly, 22 Papakyriazi Street, 41222 Larissa, Greece.
Department of Biochemistry, Faculty of Medicine, University of Thessaly, 41500 Larissa, Greece.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH